medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2020, Number 2

<< Back Next >>

Alerg Asma Inmunol Pediatr 2020; 29 (2)

Kawasaki disease and SARS-CoV-2, case report

Carrasco CA, Cuatecontzi RA, Zárate MCA, Grajales MAC, Ramírez PLR

Language: Spanish
References: 30
Page: 52-58
PDF size: 323.39 Kb.


ABSTRACT

Kawasaki disease (KD) is a vasculitis of the small and medium caliber vessels. Outbreaks of cases with KD and a few others with multisystemic inflammatory syndrome in children (MIS-C) have recently been reported in the pandemic for the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). We describe the case of a 10-month-old baby admitted and diagnosed with classical KD, who also tested positive for SARS-CoV-2 infection and had a good response to treatment with intravenous immunoglobulin and high doses of acetylsalicylic acid. The case is justified by the clinical presentation of pediatric COVID-19 and the possible association with KD.


REFERENCES

  1. Se confirma en México caso importado de coronavirus COVID-19. Disponible en: https://www.gob.mx/salud/prensa/077-se-confirma-en-mexico-caso-importado-de-coronavirus-covid-19?idiom=es

  2. Actualización epidemiológica. Nuevo coronavirus (COVID-19). 28 de febrero de 2020. Organización Panamericana de la Salud. Disponible en: https://www.paho.org/sites/default/files/2020-02/2020-feb-28-phe-actualizacion-epi-covid19.pdf

  3. Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020. Disponible en: https://www.who.int/es/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

  4. Secretaría de Salud. Proceso de prevención de infecciones para las personas con COVID-19 (enfermedad por SARS-CoV-2) contactos y personal de salud. CDMX: s.n., 2020. Lineamientos.

  5. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC Weekly. 2020; 2 (8): 113-122.

  6. Dirección General de Epidemiología. Datos Abiertos COVID-19 [base de datos al 29/04/2020]. Secretaría de Salud; 2020.

  7. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (14): 422-426. doi: 10.15585/mmwr.mm6914e4.

  8. Lu X, Zhang L, Du H et al. SARS-CoV-2 infection in children. N Engl J Med. 2020; 382 (17): 1663-1665.

  9. Colonna C, Monzani NA, Rocchi A, Gianotti R, Boggio F, Gelmetti C. Chilblain-like lesions in children following suspected COVID-19 infection. Pediatr Dermatol. 2020; 10.1111/pde.14210.

  10. Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr. 2018; 6: 374.

  11. McCrindle BW, Rowley AH, Newburger JW et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017; 135: e927-e999. doi: 10.1161/CIR.0000000000000484.

  12. Barrios Tascón A, Centeno Malfaz F, Rojo Sombrero H, Fernández-Cooke E, Sánchez-Manubens J, Pérez-Lescure Picarzo J et al. Consenso nacional sobre el diagnóstico, tratamiento y seguimiento cardiológico de la enfermedad de Kawasaki. An Pediatr (Barc). 2018; 89: 188.e1-188.e22.

  13. Pediatric Intensive Care Society. PICS Statement: Increased number of reported cases of novel presentation of multi-system inflammatory disease. [April 27, 2020] Available in: https://picsociety.uk/wpcontent/uploads/2020/04/PICS-statement-re-novel-KD-C19-presentation-v2-27042020.pdf

  14. Shulman ST. Kawasaki disease. In: Feigin RD, Cherry JD, editors. Textbook of pediatrics infectious disease. 5th ed. Philadelphia: Saunders; 2004. pp. 1055-1074.

  15. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967; 16: 178-222.

  16. Maconochie IK. Kawasaki disease. Archives of Disease in Childhood - Education and Practice Edition. 2004; 89: ep3-ep8.

  17. Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004; 110: 2747-2771.

  18. Son MBF, Newburger JW. Kawasaki disease. Pediatr Rev. 2018; 39 (2): 78-90. doi: 10.1542/pir.2016-0182.

  19. Rowley AH, Baker SC, Shulman ST et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis. 2004; 190: 856-865.

  20. Rowley AH, Shulman ST, Mask CA et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis. 2000; 182: 1183-1191.

  21. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis. 2005; 191: 499-502.

  22. Mcintosh K. Coronaviruses in the limelight. J Infect Dis. 2005; 191: 489-491.

  23. Shimizu Ch, Shike H, Baker SC, García F, van der Hoek L, Kuijpers TW et al. Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease. J Infect Dis. 2005; 192: 1767-1771.

  24. The Royal College of Paediatrics and Child Health is a registered charity in England and Wales (1057733) and Scotland (SCO 38299), 1 de mayo de 2020.

  25. World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19, Scientific Brief. [15 May 2020] Available in: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19

  26. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974; 54: 271-276.

  27. Shulman ST, Rowley AH. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 2015; 11: 475-482.

  28. Nakamura Y, Yashiro M, Uehara R et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol. 2012; 22: 216-221.

  29. Marchesi A, Tarissi de Jacobis I, Rigante D et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr. 2018; 44: 102.

  30. McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020; 19 (6): 102537.




2020     |     www.medigraphic.com